The short- and long-term outcomes in living-donor liver transplantation using small-for-size graft: A systematic review and meta-analysis

被引:3
作者
Kim, Ki-Hun [1 ,2 ]
Kim, Sang-Hoon [1 ]
Cho, Hwui-Dong [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Surg,Div Liver Transplantat & Hepatobiliary S, Seoul, South Korea
[2] 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
关键词
Graft -to -recipient weight ratio; Living -donor liver transplantation; Small -for -size graft; Small -for -size syndromes; meta; -analysis; RECIPIENT WEIGHT RATIO; PORTAL FLOW; MODULATION; INFLOW; IMPACT; VOLUME; PROGNOSIS; RISKS; VEIN;
D O I
10.1016/j.trre.2023.100747
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: A standard graft-to-recipient weight ratio (GRWR) >= 0.8% is widely accepted in living-donor liver transplantation (LDLT); however, the potential donor pool is expanded to patients adopting small-for-size graft (SFSGs) with GRWR <0.8%. This study aimed to investigate the effect of SFSG on short-and long-term outcomes following LDLT. Methods: Electronic databases were searched from January 1995 to January 2022 for studies comparing short-or long-term outcomes between patients with SFSG (GRWR <0.8%, SFSG group) and sufficient volume graft (GRWR >= 0.8%, non-SFSG group). The primary outcomes were one-, three-, and five-year overall survival (OS) and graft survival (GS), while the secondary outcome was postoperative complications. Results: Twenty-four studies comprising 7996 patients were included. In terms of OS, SFSG group had poor three-year OS (HR: 1.48, 95% CI [1.01, 2.15], p = 0.04), but there were no significant differences between two groups in one-year OS (HR: 1.50, 95% CI [0.98, 2.29], p = 0.06) and five-year OS (HR: 1.40, 95% CI [0.95, 2.08], p = 0.02). In GS, there were no significant differences in one-year (HR 1.31, 95% CI [1.00, 1.72], p = 0.05), three-year (HR 1.33, 95% CI [0.97, 1.82], p = 0.07), and five-year GS (HR 1.17, 95% CI [0.95, 1.44], p = 0.13). The SFSG group had comparable postoperative complications, except for a high incidence of vascular complications and small-for-size syndromes. Conclusions: Expanding the potential donor pool in LDLT to SFSG with GRWR <0.8% can be acceptable in terms of comparable long-term OS and GS, despite the risk for vascular complications and small-for-size syndrome.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Which is better to use "body weight" or "standard liver weight", for predicting small-for-size graft syndrome after living donor liver transplantation?
    Toshima, Takeo
    Yoshizumi, Tomoharu
    Shimagaki, Tomonari
    Wang, Huanlin
    Kurihara, Takeshi
    Nagao, Yoshihiro
    Itoh, Shinji
    Harada, Noboru
    Mori, Masaki
    [J]. ANNALS OF GASTROENTEROLOGICAL SURGERY, 2021, 5 (03): : 363 - 372
  • [22] Haemolytic uraemic syndrome after living-donor liver transplantation: Is small-for-size graft a potential risk factor?
    Luo, Y.
    Zhang, A.
    Huang, H.
    Zheng, S.
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2008, 36 (03) : 599 - 604
  • [23] Impact of graft-to-recipient weight ratio on small-for-size syndrome following living donor liver transplantation
    Bell, Richard
    Pandanaboyana, Sanjay
    Upasani, Vivek
    Prasad, Raj
    [J]. ANZ JOURNAL OF SURGERY, 2018, 88 (05) : 415 - 420
  • [24] Alleviating the Burden of Small-for-Size Graft in Right Liver Living Donor Liver Transplantation Through Accumulation of Experience
    Chan, S. C.
    Lo, C. M.
    Ng, K. K. C.
    Fan, S. T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (04) : 859 - 867
  • [25] Staged ligation of large portosystemic collaterals in living donor liver transplantation using a small-for-size graft
    Chen, Chao-Long
    Yong, Chee-Chien
    Co, Jeffrey Samuel
    Chen, Chih-Yi
    Ong, Aldwin
    Lin, Chih-Che
    Cheng, Yu-Fan
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (04) : 555 - 557
  • [26] Pharmacokinetics of cyclosporine a after massive hepatectomy: A hint for small-for-size graft in living donor liver transplantation
    Shinohara, Hisamitsu
    Shimada, Mitsuo
    Ogasawara, Takashi
    Morine, Yuji
    Ikemoto, Tetsuya
    Imura, Satoru
    Fujii, Masahiko
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (10) : 2490 - 2496
  • [27] Pharmacokinetics of Cyclosporine A After Massive Hepatectomy: A Hint for Small-for-Size Graft in Living Donor Liver Transplantation
    Hisamitsu Shinohara
    Mitsuo Shimada
    Takashi Ogasawara
    Yuji Morine
    Tetsuya Ikemoto
    Satoru Imura
    Masahiko Fujii
    [J]. Digestive Diseases and Sciences, 2007, 52 : 2490 - 2496
  • [28] Strategies in management of small-for-size graft in recipients of right lobe graft in living donor liver transplantation: a retrospective study
    Sharaf, Hesham
    Abd El Hamed, Mohamed Abd El Sattar
    Elghandour, Abdelrahman M.
    Elsaid, Kamal
    [J]. EGYPTIAN JOURNAL OF SURGERY, 2023, 42 (01) : 49 - 58
  • [29] Risk factors for biliary strictures and leaks after living-donor liver transplantation: a systematic review and meta-analysis
    Hassouneh, Ramzi
    Beran, Azizullah
    Rosenheck, Michael
    Sosio, Jessica
    Olchawa, Nicholas
    Kubal, Chandrashekhar
    Ghabril, Marwan
    Gromski, Mark A.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 28 (11) : 1870 - 1882
  • [30] The outcomes of pediatric living donor liver transplantation using small-for-size grafts: experience of a single institute
    Naoya Yamada
    Yukihiro Sanada
    Yuta Hirata
    Noriki Okada
    Yoshiyuki Ihara
    Hideki Sasanuma
    Taizen Urahashi
    Yasunaru Sakuma
    Yoshikazu Yasuda
    Koichi Mizuta
    [J]. Pediatric Surgery International, 2016, 32 : 363 - 368